Analysis of Alzheimer's drug renews hope
Linkedin

Analysis of Alzheimer's drug renews hope

Stockholm : Sweden | Sep 11, 2012 at 7:02 PM PDT
Source: San Francisco Chronicle
XX XX
Views: Pending
 
Johnson & Johnson and Pfizer Inc. 's bapineuzumab, an experimental drug that failed to help Alzheimer's symptoms in a study, showed signs of reducing physical damage in the brain, according to a deeper analysis. The medicine lessened a measure of nerve cell damage in the brain and the buildup of amyloid... FULL ARTICLE AT San Francisco Chronicle
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.